Hims & Hers Health Inc [HIMS] stock is trading at $42.55, up 5.14%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HIMS shares have gain 14.14% over the last week, with a monthly amount glided 53.78%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on January 10, 2025, when Citigroup downgraded its rating to a Sell and also boosted its price target to $25 from $24. Previously, BTIG Research started tracking the stock with Buy rating on January 07, 2025, and set its price target to $35. On December 17, 2024, Morgan Stanley initiated with a Overweight rating and assigned a price target of $42 on the stock. BofA Securities downgraded its rating to a Underperform. Needham initiated its recommendation with a Buy and recommended $24 as its price target on August 22, 2024. Imperial Capital downgraded its rating to In-line for this stock on August 09, 2024. In a note dated May 22, 2024, Citigroup downgraded an Neutral rating on this stock and boosted its target price from $16 to $20.
Hims & Hers Health Inc [HIMS] stock has fluctuated between $9.14 and $44.43 over the past year. Currently, Wall Street analysts expect the stock to reach $25.86 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $42.55 at the most recent close of the market. An investor can expect a potential drop of -39.22% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Hims & Hers Health Inc [NYSE:HIMS] reported sales of 1.24B for the trailing twelve months, which represents a growth of 77.13%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.27 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 40.68 points at the first support level, and at 38.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 45.21, and for the 2nd resistance point, it is at 47.88.
Ratios To Look Out For
For context, Hims & Hers Health Inc’s Current Ratio is 2.14. In addition, the Quick Ratio stands at 1.82 and the Cash Ratio stands at 1.08. Considering the valuation of this stock, the price to sales ratio is 7.48, the price to book ratio is 21.06 and price to earnings (TTM) ratio is 98.43.
Transactions by insiders
Recent insider trading involved Okupe Oluyemi, Chief Financial Officer, that happened on Feb 04 ’25 when 11581.0 shares were sold. Chief Executive Officer, Dudum Andrew completed a deal on Jan 31 ’25 to sell 100000.0 shares. Meanwhile, Chief Legal Officer Boughton Soleil sold 4153.0 shares on Feb 03 ’25.
